论文部分内容阅读
目的 随访新辅助化疗(NAC)实现病理完全反应(pCR)和无病理反应(non-pCR)的乳腺癌病人,比较胆碱复合物(tCho)浓度与肿瘤大小的改变。方法 本研究由伦理审查委员会批准并符合HIPAA,得到病人知情同意。
Objective To investigate the changes of tCho concentration and tumor size in neoadjuvant chemotherapy (NAC) patients with pathologically complete (pCR) and non-pCR breast cancer. Methods This study was approved by Ethics Review Board and conforms to HIPAA with patient informed consent.